Bellevue Life Sciences Acquisition Corp.
BLAC · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$2,022 | $404 | -$35 | -$3 |
| Dep. & Amort. | $0 | $0 | $0 | $0 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $0 | $0 | $0 | $0 |
| Change in WC | $0 | $1,553 | $31 | $3 |
| Other Non-Cash | -$166 | -$2,775 | $0 | $0 |
| Operating Cash Flow | -$2,188 | -$819 | -$4 | -$0 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | $0 | $0 | $0 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $35,908 | -$33,830 | $0 | $0 |
| Investing Cash Flow | $35,908 | -$33,830 | $0 | $0 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | -$1,200 | $800 | $100 |
| Stock Issued | $0 | $63,970 | -$683 | -$167 |
| Stock Repurch. | $0 | -$35,996 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | -$33,669 | $7,765 | -$676 | $10 |
| Financing Cash Flow | -$33,669 | $34,539 | $124 | -$57 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | $51 | -$109 | $120 | -$58 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $15 | $125 | $5 | $63 |
| End Cash | $66 | $15 | $125 | $5 |
| Free Cash Flow | -$2,188 | -$819 | -$4 | -$0 |